Albemarle Corporation
NYSE:ALBChemicals - Specialty
-$6.21 today
- Market cap
- $10.13B
- Beta
- 1.31
- P/E (TTM)
- -81.1
- EPS (TTM)
- -$1.98
- Dividend yield
- 1.01%
Volume 2.16M
Average 2.29M
ALB Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Albemarle CorporationNYSE: ALB
Other Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other non-current liabilities rises 51.9% from a year ago
Other non-current liabilities stood at $1.25B at the end of Q2 FY2026, up 51.9% from a year earlier and down 2.6% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Other non-current liabilities amounted to 7.8% of total assets at the end of Q2 FY2026, up 3.1 pp from a year earlier.
- Other non-current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +51.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 863.33M USD
- Year-over-year change
- +9.3%
- 4-year CAGR
- +1.6%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 863.33M | +9.3% |
| FY2024 | 2024-12-31 | 789.79M | +4.8% |
| FY2023 | 2023-12-31 | 753.95M | +3.3% |
| FY2022 | 2022-12-31 | 729.65M | -9.9% |
| FY2021 | 2021-12-31 | 809.58M | — |
Other Non-current Liabilities vs competitors
How ALB compares with its peers on the latest reported figures
- ALB's Jun 2026 other non-current liabilities of $1.25B is the highest of the 4 companies compared; the peer median is $104.4M.
- Its year-over-year change of +51.9% is the 2nd highest of 4, against a peer median of +4.7%.
- Other non-current liabilities amounts to 7.8% of total assets for ALB, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.25B | +51.9% | +5.8% | 7.8% | |
| Mar 2026 | $202.68M | +723.5% | +740.5% | 6.5% | |
| Jun 2026 | $104.4M | +0.4% | -26.2% | 0.6% | |
| Mar 2026 | $604.98K | +4.7% | — | 0.2% | |
| Peer median (excluding ALB) | $104.4M | +4.7% | +357.2% | 0.6% | |
Competitors are the stored peer set for ALB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 439.27M | 1.5B | 889.9M | 1.19B | 1.62B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 700.06M | 1.45B | 1.84B | 1.07B | 764.77M |
| Inventory | 798.62M | 2.08B | 2.16B | 1.5B | 1.18B |
| Other Current Assets | 5.8M | 6.72M | 6.6M | 4.75M | 374.19M |
| Total Current Assets | 1.99B | 5.19B | 5.22B | 3.84B | 4.01B |
| Property, Plant & Equipment (Net) | 6.06B | 7.09B | 9.63B | 9.45B | 8.73B |
| Goodwill | 1.6B | 1.62B | 1.63B | 1.58B | 1.5B |
| Intangible Assets | 308.95M | 287.87M | 261.86M | 230.75M | 214.23M |
| Long-term Investments | 912.01M | 1.15B | 1.37B | 1.12B | 900.93M |
| Tax Assets | 18.8M | 46.43M | 22.43M | 53.61M | 17.54M |
| Other Non-current Assets | 78.7M | 75.95M | 137.25M | 332.26M | 1B |
| Total Non-current Assets | 8.98B | 10.27B | 13.05B | 12.77B | 12.37B |
| Total Assets | 10.97B | 15.46B | 18.27B | 16.61B | 16.37B |
| Account Payables | 647.99M | 2.05B | 2.09B | 943.89M | 913.53M |
| Short-term Debt | 389.92M | 2.13M | 625.76M | 398.02M | 74.08M |
| Tax Payables | 27.67M | 134.88M | 255.16M | 95.28M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 2.12M | 93.09M |
| Other Current Liabilities | 100.72M | 145.89M | 168.36M | 157.15M | 331.96M |
| Total Current Liabilities | 1.87B | 2.74B | 3.56B | 1.97B | 1.8B |
| Long-term Debt | 2B | 3.21B | 3.54B | 3.12B | 3.12B |
| Deferred Tax Liabilities | 353.28M | 480.77M | 558.43M | 358.03M | 368.28M |
| Deferred Revenue (Non-current) | 0 | 0 | 78.03M | 78.03M | 340.53M |
| Other Non-current Liabilities | 809.58M | 729.65M | 753.95M | 789.79M | 863.33M |
| Total Non-current Liabilities | 3.29B | 4.52B | 5.05B | 4.44B | 4.79B |
| Total Liabilities | 5.17B | 7.27B | 8.61B | 6.41B | 6.59B |
| Common Stock | 1.17M | 1.17M | 1.17M | 1.18M | 1.18M |
| Retained Earnings | 3.1B | 5.6B | 6.99B | 5.48B | 4.61B |
| Accumulated OCI | (392.45M) | (560.66M) | (528.53M) | (742.06M) | (334.81M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 180.34M | 208.22M | 252.92M | 238.17M | 248.1M |
| Total Equity | 5.81B | 8.19B | 9.67B | 10.2B | 9.78B |
| Total Debt | 2.52B | 3.32B | 4.28B | 3.62B | 3.3B |
| Net Debt | 2.08B | 1.82B | 3.39B | 2.42B | 1.68B |
Albemarle Corporation
NYSE:ALB
Intrinsic Alpha fair value
Locked
Current Price
$85.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.